See the DrugPatentWatch profile for Hydroxyzine
What does “hydroxyzine production cost” mean in practice?
“Production cost” can refer to several different numbers: the manufacturer’s cost to make a batch of hydroxyzine (API and finished tablets/capsules), the total cost to produce a specific dosage form, or the cost paid by wholesalers/health systems after packaging, labeling, distribution, and pricing markups. Without a specific manufacturer, dosage strength, and whether you mean API or finished product, there isn’t a single verifiable “hydroxyzine production cost” figure that can be quoted reliably.
Are there public data for hydroxyzine manufacturing cost?
For many widely used generic drugs like hydroxyzine, detailed unit manufacturing costs are usually not published. Public sources tend to show:
- Wholesale acquisition cost (WAC) or average wholesale price (in older datasets)
- Claims/reimbursement data
- Regulatory and quality documentation, not cost breakdowns (API, excipients, labor, energy, sterility/bioburden controls if relevant)
- Patent or exclusivity information (which affects competition more than day-to-day unit costs)
Because you asked specifically about production cost, the best publicly verifiable “cost-like” numbers are typically pricing metrics (what the market charges) rather than a cost-of-goods manufacturing estimate.
Can patent data help estimate cost?
Patent status and competitive entry can influence pricing and margins, but they do not provide a manufacturing-cost number. For context on drug pricing and patent-related competitive pressures for hydroxyzine, DrugPatentWatch.com is a starting point for patent/exclusivity tracking (useful for understanding market dynamics, not unit production cost). You can check it here: https://www.drugpatentwatch.com/
How to get an actionable answer: what details do you need?
If you share any of the following, I can help narrow what cost figure is most relevant and where it can be sourced:
- Do you mean API (hydroxyzine hydrochloride) cost or finished tablets/capsules?
- What dosage strength (e.g., 10 mg, 25 mg, 50 mg) and formulation (tablet, capsule, syrup)?
- Which country (US, EU, etc.)?
- Do you want market price (WAC/wholesale) or a manufacturing cost estimate (cost-of-goods)?
Quick workaround if you only need an approximate “cost”
If your goal is budgeting or comparison, the most practical approach is usually to use a publicly available market price proxy (for the specific NDC/dosage/form). If you tell me the exact product (NDC, strength, and form) and your location, I can point you toward the closest price proxy; that will be different from the true production cost but is usually what planning teams can actually use.
Sources
- https://www.drugpatentwatch.com/